ACAD
ACADIA Pharmaceuticals Inc.
NASDAQ · USHealthcareBiotechnology
$25.09-1.99%
Price as of Jul 20, 2026
ACAD capital
ACADIA Pharmaceuticals Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.03x
- Debt / EBITDA
- 0.40x
- Net debt / EBITDA
- -1.82x
Liquidity & coverage
- Current ratio
- 3.59x
- Quick ratio
- 3.48x
- Cash ratio
- 2.79x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $790.5M
Cash & dividend
- FCF / debt
- 4.18x
- Cash flow / debt
- 2.43x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.